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Abstract
Background: Successful management of diabetes requires attention to the behavioural, psychological and social
aspects of this progressive condition. The Diabetes MILES (Management and Impact for Long-term Empowerment
and Success) Study is an international collaborative. Diabetes MILES–Australia, the first Diabetes MILES initiative to
be undertaken, was a national survey of adults living with type 1 or type 2 diabetes in Australia. The aim of this
study was to gather data that will provide insights into how Australians manage their diabetes, the support they
receive and the impact of diabetes on their lives, as well as to use the data to validate new diabetes outcome
measures.
Methods/design: The survey was designed to include a core set of self-report measures, as well as modules
specific to diabetes type or management regimens. Other measures or items were included in only half of the
surveys. Cognitive debriefing interviews with 20 participants ensured the survey content was relevant and easily
understood. In July 2011, the survey was posted to 15,000 adults (aged 18-70 years) with type 1 or type 2 diabetes
selected randomly from the National Diabetes Services Scheme (NDSS) database. An online version of the survey
was advertised nationally. A total of 3,338 eligible Australians took part; most (70.4%) completed the postal survey.
Respondents of both diabetes types and genders, and of all ages, were adequately represented in both the postal
and online survey sub-samples. More people with type 2 diabetes than type 1 diabetes took part in Diabetes
MILES–Australia (58.8% versus 41.2%). Most respondents spoke English as their main language, were married/in a
de facto relationship, had at least a high school education, were occupied in paid work, had an annual household
income > $AUS40,000, and lived in metropolitan areas.
Discussion: A potential limitation of the study is the under-representation of respondents from culturally and
linguistically diverse backgrounds (including Aboriginal and Torres Strait Islander origin). Diabetes MILES–Australia
represents a major achievement in the study of diabetes in Australia, where for the first time, the focus is on
psychosocial and behavioural aspects of this condition at a national level.
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Background
Diabetes is a common and progressive long-term condi-
tion, which places a significant burden of self-manage-
ment on the individual. The prevalence of all types of
diabetes is increasing, with type 2 diabetes growing at
epidemic proportions [1]. The total number of people
with diabetes worldwide was conservatively estimated to
increase from 171 million in 2000 to 366 million in
2030 [2].
Self-management of diabetes (in all its forms) is a
complex behavioural and social process, requiring not
only a comprehensive understanding of the condition
but also high levels of self-efficacy, perceived control
and empowerment [3]. Unsurprisingly, having diabetes
can negatively impact the quality of life of people living
with the condition [4,5]. A considerable number of stu-
dies have found relatively high levels of distress, and, in
a substantial minority, significant depressive symptoma-
tology [6]. Furthermore, the onset of complications
(such as retinopathy, neuropathy, kidney damage, heart
disease and stroke) can exacerbate the psychological
impact of this progressive condition [7]. Thus, the asso-
ciation between diabetes and psychological burden
appears to be a vicious cycle and we need to identify
ways to reduce this burden. In addition to understand-
ing the psychological health and well-being of people
with diabetes, research is needed to establish a greater
understanding of perceptions and misconceptions
among people with diabetes, their health beliefs and the
personal values which inform their self-management.
Such research has been concentrated for the most part
in the US and Europe, with very little being conducted
in Australia. The Diabetes Attitudes Wishes and Needs
(DAWN) Study is probably the only large-scale study
that has focused on the psychological impact of diabetes
and the implications for improvements to health care
for people with diabetes [8]. This cross-national study,
which included an Australian sample, highlighted the
importance of a positive and collaborative relationship
between health care providers and people with diabetes
[9], as well as the relatively high prevalence of diabetes-
related distress amongst people with diabetes [10], and
the role of psychological and social barriers to self-care
and medication initiation and management [11,12]. The
DAWN Study highlighted important avenues for future
research into the psychological aspects of living with
diabetes that need to be pursued in Australia. DAWN 2,
a related study with increased breadth, is currently
underway but Australia is not included in this new
initiative.
The Living With Diabetes Study is a population-based
cohort study of the quality of life and well-being of peo-
ple with diabetes living in Queensland, Australia [13].
One of the primary aims of this study is to evaluate a
state-based strategy for the management of chronic con-
ditions, and thus the Living With Diabetes Study has
been undertaken in one Australian state only.
The Diabetes MILES Study has been established as an
international collaborative, the aim of which is to con-
duct a series of national surveys of people with type 1
or type 2 diabetes in various countries. Diabetes
MILES–Australia is the first Diabetes MILES initiative,
and was conceived to provide a national survey of the
psychological health, self-care beliefs and activities, and
unmet needs of Australians living with type 1 or type 2
diabetes. The Diabetes MILES–Australia 2011 survey
was built on four central themes: management, impact,
empowerment, and success.
Survey themes
Management
The burden of the management of diabetes falls largely
to the individual living with the condition. Self-manage-
ment, or self-care, activities are crucial for achieving and
maintaining optimal blood glucose levels, and prevent-
ing diabetes-related complications. Self-care is defined
as ‘activities that individuals, families and communities
undertake with the intention of enhancing health, pre-
venting disease, limiting illness and restoring health.
They are undertaken by lay people on their own behalf,
either separately or in participative collaboration with
health professionals’ [14]. Diabetes self-care can involve
dietary modifications, taking medications as recom-
mended, regular physical activity, foot care and self-
monitoring of blood glucose.
Self-care requires not only a comprehensive under-
standing of diabetes but also belief in one’s capabilities,
motivation to perform complex self-care activities, and a
supportive environment (of family, friends and health
care professionals). Self-care is central to both the
experience of living with diabetes and the optimisation
of diabetes outcomes, and thus ongoing research in this
area is essential.
Impact
International reviews have found clinical levels of
depression in up to 12% of people with type 1 diabetes
and 18% of people with type 2 [15,16]. Many more are
likely to report some level of diabetes-related distress [6]
and, on average, diabetes has a negative impact on qual-
ity of life [5]. Understanding the psychological, emo-
tional, and social impact of diabetes is essential for the
development and evaluation of new therapies and inter-
ventions, including but not limited to psychological
therapies. For example, identifying the negative impact
of diabetes on dietary freedom [5] was instrumental in
hypothesising that the Dose Adjustment For Normal
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Eating (DAFNE) program [17] would offer substantial
benefits for quality of life, benefits which have been
well-maintained for up to four years in combination
with partially maintained improvements in glycaemic
levels [18]. We need to advance our understanding of
the psychological, emotional, and social impact of dia-
betes so that care and support for people living with the
condition can be optimised.
Empowerment
A person with diabetes who is empowered has high per-
ceived self-efficacy, is actively engaged in their own health
care (including self-care), and seeks out necessary support
and information. Empowerment is undoubtedly philoso-
phically desirable, and importantly, evidence suggests that
it is the only way to achieve optimal, sustainable long-
term outcomes [19]. Unfortunately, it can be rare in every-
day clinical practice, where both the health care profes-
sional and person with diabetes often adopt traditional
roles, which can result in the person with diabetes becom-
ing a passive recipient of health care and feeling de-moti-
vated. Access to diabetes education and utilisation of
healthcare resources are examples of the means through
which people with diabetes can be empowered to best
manage their condition, and both are critical in achieving
optimal biomedical outcomes in diabetes. Education and
support programs are known to enhance self-management
and improve psychosocial outcomes but are not widely
available. Figures from the UK national diabetes audit [20]
indicate that a large proportion of people with diabetes are
not undergoing the regular checks recommended for care-
ful monitoring of their condition. It is important to under-
stand the role of empowerment in successful diabetes
management and utilisation of services, and to subse-
quently promote and facilitate patient empowerment in
health care and other settings.
Success
In addition to understanding the psychological health
and well-being of Australians with diabetes, research is
needed to develop a greater understanding of the role of
health beliefs, and the personal values which inform
self-management and willingness to engage with treat-
ments as recommended by health care professionals.
Health beliefs (e.g. perceived severity of disease, per-
ceived efficacy of treatment) and aspects of positive
mental health (such as resilience, self-esteem, optimism)
are important mediators of diabetes outcomes [21-23].
Hardiness, is associated with lower distress; low rates of
complications and is a good predictor of optimal out-
comes, independent of education [22]. Social and peer
support is also implicated in better outcomes [24,25]. It
is important to further examine the role of a person’s
disposition, and their social context, in contributing to
living successfully with diabetes [26].
Aims
The primary aims of Diabetes MILES–Australia are to:
• conduct a large-scale survey of Australian adults
with type 1 or type 2 diabetes with a focus on
exploring the psychological, behavioural and social
factors relevant to living with diabetes
• ensure the suitability of the survey as the baseline
for a longitudinal (repeated cross-sectional and
cohort) study
• use the results to raise awareness of the psycholo-
gical health and unmet needs of Australian adults
living with diabetes.
Primary research questions to be addressed by Dia-
betes MILES–Australia include (but are not limited to):
• What characterises living successfully with dia-
betes? (e.g. long diabetes duration with minimal
physical complications and optimal psychological
health)
• What is the prevalence of impaired awareness of
hypoglycaemia and severe hypoglycaemia among
people with type 1 diabetes?
• What are unmet needs of Australian adults living
with diabetes?
• What is the impact of diabetes on the well-being of
Australians living with the condition?
• Is the Quality of Life Questionnaire–Diabetes [27]
a valid and reliable measure of the impact of dia-
betes on quality of life?
• Is the Diabetes Self-Care Inventory–Revised a valid
and reliable measure of self-care beliefs, attitudes,
and behaviours?
• Are postal and internet-based surveys equally sui-
table methods for conducting a national survey?
• How do two measures of diabetes-related distress
(the Diabetes Distress Scale (DDS)[28] and the Pro-
blem Areas In Diabetes questionnaire (PAID)[29])
compare in terms of psychometric properties and
utility?
• What is the prevalence of clinically significant
depression, anxiety and diabetes-related distress in
Australian adults living with diabetes?
Methods/design
Ethics approval
Ethics approval was granted by Deakin University
Human Research Ethics Committee (reference number
2011-046). A plain language statement and consent
form were developed for the cognitive debriefing phase
as well as for the main national survey.
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Establishment of the reference group
A multidisciplinary reference group was established
comprising 32 representatives from psychology, nursing,
population health, health economics, pharmacy, endocri-
nology, and general practice (see http://www.diabetes-
MILES.org). Most reference group members are
Australian but eight international academics are also
involved. The role of the reference group was to advise
on survey content (concepts, measures and individual
variables) and research questions. An important ongoing
role for the reference group is to collaborate on dissemi-
nation of the survey results.
Phase 1: Selection of psychological measures
The Diabetes MILES–Australia 2011 survey was devel-
oped through the following process: initial measure
selection occurred after phases of measure identification,
assessment and consultation, cognitive debriefing of
standardised measures and survey-specific items before
survey distribution.
Identification
Within each study theme (management, impact,
empowerment and success) a number of relevant con-
cepts were identified. For each concept a questionnaire
search was completed. Measures were considered for
use only if they were appropriate for use with adults
(aged 18-70 years) and were designed for any of the fol-
lowing population types: generic, diabetes specific,
chronic condition specific.
Assessment
For each measure the following information was col-
lected and assessed: length, reliability and validity, pre-
vious use in Australia and internationally, and use
within diabetes-specific populations.
A number of important concepts of the study were
not adequately or succinctly measured through already
established questionnaires, necessitating the drafting of a
number of items by the research team at this point. It
became clear that several measures had not been vali-
dated for use in Australia but one of the pivotal roles of
Diabetes MILES–Australia is to provide the dataset
upon which psychometric validation can be conducted.
Linguistic validation (i.e. the extent to which measures
were suitable for use in English for Australia) was con-
sidered during selection by the research team (two of
whom are Australian) and through cognitive debriefing
(see below) with Australians living with diabetes.
Consultation
After the initial assessment had been made, an item-
bank was compiled for consideration by the wider refer-
ence group who were asked to contribute detailed feed-
back and suggestions for further development of the
item-bank. The item-bank was circulated for consulta-
tion three times. On each occasion the feedback
received either confirmed the use of an identified mea-
sure or led to identification and assessment of other
measures. The Principal Investigator (JS) and the
research team made all final decisions regarding the sur-
vey content.
Phase 2: Pilot study and cognitive debriefing
The aim of the pilot study was to ensure that the survey
content was relevant and suitable for Australian adults
with type 1 or type 2 diabetes. This involved asking par-
ticipants to complete the survey and then take part in a
cognitive debriefing (CD) interview.
Recruitment
Participants were recruited through advertisements in
relevant diabetes media (Diabetes Australia-Vic maga-
zines, websites and e-newsletters) in the state of Victoria.
Potential participants contacted the research team by tel-
ephone or email and they were sent (by email, post or
fax) a copy of the plain language statement, and a con-
sent form to sign. Participants were eligible if they met
the inclusion criteria for the larger national survey sam-
ple (see below). Decisions regarding recruitment were
based on responses to a brief set of screening questions.
This ensured a representative sample, relevant to the
aims of this phase of the study (i.e. an adequate mix of
men/women, ages, diabetes types and treatment, educa-
tion levels and occupations). In addition, participants
needed to be willing to attend interviews held in Mel-
bourne city centre, Burwood (suburb of Melbourne) or
Geelong (regional city in Victoria, although no partici-
pants chose this option) to minimise travel expenses and
to enable this phase of the project to progress quickly.
Procedure
Ahead of the CD session, participants were posted a
copy of the survey booklet plus a letter requesting that
they read and/or complete the survey booklet no more
than one day before the interview. Participants were
invited to make note of any survey instructions, sections,
questions or response options which were unclear or of
concern to them. Upon arrival at the CD session, parti-
cipants were asked to provide their consent form and
were reminded of their participatory rights. All inter-
views were audio recorded in a de-identified digital for-
mat. Participants were free to refuse to answer any of
the questions.
Participants were first asked to comment on the sur-
vey as a whole in terms of relevance, readability, accept-
ability, language and length. Participants were also asked
how long it took them to complete the survey and the
extent to which they found it easy or difficult to com-
plete. Participants were then asked a number of similar
questions about each section of the survey, a selection
of specific standardised psychological measures, and
study-specific items.
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Results
CD was conducted with 20 adults living in and around
Melbourne: 12 participants with type 1 diabetes (seven
women; mean age = 43.5 ± 9.6 years (range: 25-56
years)); eight with type 2 diabetes (seven women; mean
age = 55.9 ± 15.2 years (range: 21-64 years)). The educa-
tion level of participants ranged from secondary school
to higher university degree.
Participants indicated that it took a mean of 58 min to
complete or read through the survey (range: 20-120
min). The CD interviews had a mean duration of 51
min (range: 20-109 min).
Some minor changes to the survey were made in
response to feedback received, such as improvements to
the survey booklet layout, amending instructions so they
were simpler and more consistent, and a small number
of measures were excluded from the survey to reduce its
length.
Phase 3: Finalising survey content and study materials
All survey modifications made as a result of the CD ses-
sions were approved by the Deakin University Human
Research Ethics Committee.
At the completion of this process the detailed concept
and measure index (Table 1) was finalised. This index
lists all concepts investigated in the Diabetes MILES–
Australia 2011 survey, the measures used to assess these
concepts, as well as the survey version in which the
measure was included. Minimising respondent burden
and maximising relevance (e.g. to diabetes type/treat-
ment) were crucial considerations. Thus, the item bank
was split into six surveys: an ‘A’ and ‘B’ version for each
participant group (type 1 diabetes (T1), type 2 diabetes
insulin-treated (T2I), type 2 diabetes non-insulin-treated
(T2)). This enabled inclusion of some questionnaires
which may have otherwise been excluded due to space
limitations. Core measures/items were included in all
survey versions, while others were included in only one
or two versions (details in Table 1). Completion of the
survey was expected to take approximately one hour.
Preparation of postal and online surveys
Hard copy and online versions of the survey were devel-
oped. A contract research organisation (CRO) prepared
the hard copy survey booklets in a format that enabled
responses to be scanned for automated data entry. The
online survey was designed by a web developer based in
the School of Psychology, Deakin University.
The postal survey booklets (specific to diabetes type
and treatment regimen of recipient; version A or B ran-
domly assigned) were packaged with a reply-paid envel-
ope, a plain language statement and withdrawal of
consent form, contact details form and a language other
than English (LOTE) form (both optional to complete).
For practical reasons, the survey was not available in
LOTE but survey recipients were invited to indicate if
they would like to complete a similar survey in their
own language in the future (if it became available). This
statement was translated into nine of the most com-
monly spoken languages in Australia: Arabic, Cantonese,
Greek, Italian, Macedonian, Mandarin, Spanish, Turkish,
and Vietnamese.
Phase 4a: Data collection–national postal survey
Approximately six weeks was allocated for data collec-
tion (postal survey distribution and return, and online
completion).
Study population
The postal survey was distributed to a random sample
of 15,000 registrants of the National Diabetes Services
Scheme (NDSS). The NDSS register includes approxi-
mately one million Australians diagnosed with diabetes
(e.g. type 1, type 2, gestational). NDSS registrants were
eligible for selection if they met the following inclusion
criteria:
• living with type 1 or type 2 diabetes
• aged 18 to 70 years
• previously indicated consent to be contacted about
future research; approximately 250,000 (25%) of
NDSS registrants
The sample size of 15,000 was chosen in anticipation
of a 20% response rate (N = 3,000), offering a substan-
tial dataset and enabling meaningful subgroup analyses.
The sample was stratified (based on information pro-
vided on the NDSS register) to ensure adequate repre-
sentation of specific types of diabetes and treatment
regimens:
• Type 1 diabetes: 6,000 registrants (40% of total
sample)
- 5,400 using insulin injections
- 600 using pump therapy
• Type 2 diabetes: 9,000 registrants (60% of total
sample)
- 4,500 using insulin
- 4,500 not using insulin
The sample was not stratified by gender.
Procedure
All study materials were supplied to the Diabetes Aus-
tralia–Vic mail co-ordination team who addressed and
posted all surveys. The research team had no direct
involvement in the random selection or in the handling
of potential participant contact details.
Participants received the survey package by post and
were asked to return the completed survey using the
reply-paid envelope provided before 31st July 2011. In
Speight et al. BMC Public Health 2012, 12:120
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Table 1 Concepts, measures and variables included in the Diabetes MILES–Australia 2011 Survey
Concept Measure or variable Survey
version
Part 1: Your feelings In general
Subjective Wellbeing PWI: Personal Wellbeing Index [30] ALL
Emotional Wellbeing WHO-5: World Health Organisation Well-being index [31] ALL
Depression PHQ-9: Patient Health Questionnaire [32]^ ALL
Anxiety GAD-7: General Anxiety Disorder Questionnaire [33]^ ALL
Part 2: Your feelings about diabetes
Diabetes specific quality of
life
QoL-Q Diabetes [27] ALL
Diabetes-specific distress DDS: Diabetes Distress Screening Scale [28]#; PAID: Problem Areas In Diabetes scale [29]#^ ALL
Diabetes-specific positive
well-being
4-item subscale of the W-BQ28: Wellbeing Questionnaire [34] ALL
Part 3: Your general health
General health EQ5D-5L [35]; 3 items (general health in past 4 weeks; change in health in past year)* ALL
Miscellaneous 7 items: other conditions/co-morbidities*^; sleep*; transplants*; dialysis*; weight loss surgery* ALL
Part 4: Support from health professionals
Health consultations 29 items (main health care professionals, access, reliance, distance, consistency, continuity, distance/cost
as an obstacle, timely appointment attendance)*^ inspired by the ALSHW Survey 2009
ALL
Healthcare and self-
management
RSSM: Resources and Support for chronic illness Self-Management scale [36] T1A, T2IA,
T2A
Structured education 4 items* inspired by the IDF Diabetes Atlas 2009 T1A, T2IA,
T2A
Empowerment DES-SF: Diabetes Empowerment Scale Short Form [37] ALL
Health literacy HeLMS: Health Literacy Management Scale (seven of eight subscales included) ALL
Part 5: Support from friends and family
Peer/family support 3 items* inspired by Tang et al, 2008 [38]; DFSC: Diabetes Family Support and Conflict [39], Diabetes
support group involvement*
T1B, T2IB,
T2B
Part 6: Your diabetes
Diabetes history Age at diagnosis*^; diabetes type*^; current treatment regimen*^ ALL
Blood glucose monitoring
and recording
6 items (satisfaction, monitoring, recording, action)* inspired by the DAFNE self-management
questionnaire (in development)*
ALL
Self-care behaviours &
attitudes
Diabetes Self-Care Inventory–Revised^ adapted to include smoking items* inspired by the Smoking and
Health Survey 2010 (the Cancer Council Vic)[40]
ALL
Medication adherence MARS: Medication Adherence Rating Scales [41] (Insulin and/or Medicine) ALL
Blood glucose level and
HbA1C targets
4 items*^ T1A, T2IA,
T2A
Hypoglycaemia awareness The Gold Score [42]; 5 items from the HypoA-Q: Hypo Awareness Questionnaire [43]^ T1A
Hypoglycaemia treatment 1 item* T1A
Fear of hypoglycaemia 2 items* inspired by the Hypoglycaemia Fear Scale [44] T1A
Insulin restriction Items inspired by Diabetes Australia-Vic’s Type 1 Diabetes and Eating Disorders Online Survey 2008
Report*
T1B
Disordered eating 6 items* inspired by Type 1 Diabetes and Eating Disorders Online Survey 2008 report T1B
Perceived behavioural
control
15 items* T2IB, T2B
Physical activity IPAQ: International Physical Activity Questionnaire (Short Form) [45]; 5 items* T2IB, T2B
Psychological insulin
resistance
ITAS: Insulin Treatment Appraisal Scale [46]^ T2IB, T2A
Part 7: Your thoughts and beliefs
Optimism LOT-R: Life Orientation Test–Revised [47] T1B, T2IB,
T2B
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practice, there were some late arrivals and we included
all returns received by 31st August.
Phase 4b: Data collection–national online survey
Study population
The online survey (including details of the website URL)
was advertised nationally through a variety of media:
• The NDSS website
• Diabetes Australia (national and state-based) web-
sites, magazines and newsletters (including e-
newsletters)
• posters advertising the survey were distributed
through various healthcare professional networks for
prominent placement in diabetes clinics
• newsletters/e-newsletters of a range of national and
state-based health organisations, societies, member-
ship bases (e.g. sanofi aventis, Medtronic, Type 1
Network (Reality Check))
Postal survey recipients were also offered the option to
complete the survey online (rather than by paper and
pen).
Procedure
Upon accessing the online survey, participants were
encouraged to read the plain language statement and to
tick a box to indicate informed consent to proceed. The
online survey was identical to the postal survey except
for the need to change the order of some primary ques-
tions to establish the survey version relevant for the par-
ticipants, as well as the inclusion of a question asking
how participants heard about the survey. Initial screen-
ing questions (e.g. age, type and treatment of diabetes
and ability to communicate in English) were used to
ensure that participants were eligible and to tailor the
presentation of subsequent survey questions. Partici-
pants were randomly assigned to version A or B of the
survey. Those who were ineligible were presented with a
screen thanking them for their interest and informing
them that they were ineligible to complete the rest of
the survey. The eligibility criteria were identical to those
used for the postal survey, except NDSS registration was
not a requirement.
Phase 5: Data handling and analyses
Completed postal surveys were received for initial pro-
cessing and de-identification (in the instances where the
contact details form was returned) by the research team.
De-identified surveys were then forwarded to the CRO,
accompanied by a data dictionary, for scanning and data
entry. The web developer downloaded the data from the
online survey into a spreadsheet that was also forwarded
Table 1 Concepts, measures and variables included in the Diabetes MILES–Australia 2011 Survey (Continued)
Perceived self-efficacy GSE: General Self-Efficacy Scale [48] T1B, T2IB,
T2B
Self-esteem Rosenberg Self-Esteem Scale [49] T1B, T2IB,
T2B
Beliefs about illness BIPQ: Brief Illness Perceptions Questionnaire (diabetes version) [50]^ T1A, T2IA,
T2A
Beliefs about medicines BMQ: Beliefs about Medicines Questionnaire (medicine/insulin and general) [51] T1A, T2IA,
T2A
Part 8: About you
Demographics 25 items (e.g. sex, age, weight/height, education, occupation, disability)*^ inspired by the ALSWH 2009 ALL
Financial hardship Economic Hardship Questionnaire [52]; 8 items* T1B, T2IB,
T2B
NDSS access 4 items* from previous NDSS surveys ALL
Part 9: Have we missed anything?
Further comments Free-text box ALL
Part 10: Future Research
What research would you
like to see?
Free-text box ALL
Interest in future research 2 items* ALL
* designed by research team in the absence of relevant and suitable standardised measures
# measure/item included in only 50% of surveys in order to reduce respondent burden
^ Diabetes MILES Study core measures to be included in all surveys of adults living with type 1 or type 2 diabetes (e.g. Diabetes MILES–Australia, Diabetes
MILES–The Netherlands)
ALSWH Australian Longitudinal Study on Women’s Health
Survey types: T1: Type 1 diabetes; T2I: Type 2 insulin-treated diabetes; T2: Type 2 non-insulin-treated diabetes. For each type, there was an ‘A’ and ‘B’ version.
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to the CRO for merging with the postal survey data.
The CRO then provided the research team with a data
file that contained the data from all returned surveys
(postal and online), plus scanned images of each page of
all postal surveys. All hard copies of the survey booklets
were returned to the research team for secure storage.
Statistical analyses will be performed using the Statis-
tical Package for the Social Sciences (SPSS) version 17.0.
Given the anticipated large sample size, Bonferroni cor-
rections will be used to apply more conservative signifi-
cance levels for all analyses. Differences between
subgroups will be determined using c2 tests for categori-
cal data and independent samples t-tests or ANOVAs
for continuous variables. Further analyses (e.g. principal
components analysis, multiple regression) may be used
dependent on specific research questions and will be
reported in subsequent papers as relevant. Sample char-
acteristics are presented below using frequencies (N (%))
for categorical variables and mean ± standard deviation
for continuous variables.
Response rates
In total, 3,833 people responded to the Diabetes
MILES–Australia 2011 survey:
• 987 completed the online survey, of which 220
participants indicated that they had received the
postal survey.
• 2,351 completed the postal survey or responded to
the online survey after receiving the postal version, a
response rate of 17%. However, 541 postal surveys
were returned to sender, as the addressee was no
longer at the address provided by the NDSS, or was
deceased. Thus, the adjusted response rate is 18%.
Of the total 3,833 respondents, 495 did not meet all of
the eligibility criteria (e.g. did not have type 1 or type 2
diabetes, aged younger than 18 or older than 70, could
not complete survey in English without assistance) and
were excluded from the sample. Subsequent analyses
presented in this and other papers arising from Diabetes
MILES–Australia refer only to the final sample of 3,338
eligible respondents. Response rates of eligible partici-
pants for the postal versus online surveys are presented
in Table 2.
The representativeness of the sample can be deter-
mined by comparing respondents on key characteristics
to NDSS registrants. More than half (58%) of the Dia-
betes MILES–Australia sample was from the states of
New South Wales or Victoria and by comparison, 59%
of NDSS registrants are from these two statesa. Substan-
tially smaller proportions of people from other Austra-
lian states and territories are NDSS registrants, and this
was also reflected in our study sample. Nationally, 53%
of NDSS registrants are men, as compared to 46% of
our study sample, suggesting that women were slightly
over-sampled in the Diabetes MILES–Australia studyb.
Sample characteristics
Respondents were asked to indicate their diabetes type
as well as to provide a range of demographic informa-
tion (see Table 3). People with type 2 diabetes were
more highly represented in the sample than people
with type 1 (58.8% versus 41.2%), proportionate to the
ratio of surveys distributed (60% versus 40% respec-
tively). Men and women were represented almost
equally in the sample (46.2% versus 53.8% respec-
tively). Most respondents spoke English as their main
language, were married or in a de facto relationship,
had at least a high school education, lived in metropo-
litan areas, were occupied in paid employment, and
had an annual household income of more than
$AUS40,000 (approximately $US39,600 or €30,563) per
annum. Only a very small proportion (1.7%) of respon-
dents were from an Aboriginal and/or Torres Strait
Islander (ATSI) background, and only 3% of the total
sample indicated that they mainly spoke a language
other than English at home. However, 25.4% of
respondents indicated that they were born in a country
other than Australia, which is representative of the
broader Australian population [53].
Qualitative feedback
Participants who took part in the CD interviews identi-
fied that this study “is not trying to understand [dia-
betes] from a medical point of view but from a
psychological point of view...because depression and dia-
betes...are best of friends“ (male, 25 years, type 1 dia-
betes). We found that people with diabetes were
frustrated with the current health ‘system’ and that this
survey asked questions which “usually no one asks“
(female, 58 years, type 2 diabetes). The “questions were
quite probing...they scratched beneath the surface“ (male,
44 years, type 1 diabetes). One individual commented
“someone has finally done it...its needed.... there’s so
much frustration...within the diabetic system....when’s it’s
all put together in voice and collected as a whole it’s
easy to get out there“(male, 25 years, type 1 diabetes).
Overall, Diabetes MILES–Australia has received a great
deal of positive feedback from people with diabetes.
Discussion
To our knowledge, Diabetes MILES–Australia is the lar-
gest national survey of the impact of living with diabetes
ever performed in Australia; the largest in terms of sam-
ple size but also in terms of the breadth and depth of
questioning. Diabetes MILES–Australia represents the
first opportunity of its kind to assess the psychological
Speight et al. BMC Public Health 2012, 12:120
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health and unmet needs of a large and diverse sample of
Australian adults with type 1 or type 2 diabetes. The
dissemination of findings from Diabetes MILES–Austra-
lia over several years will raise awareness of the psycho-
logical and social impact of diabetes, as well as
highlighting key associations between factors such as
health status, health beliefs, social support, self-care,
empowerment and a range of psychological outcomes.
Findings will inform future research projects specific to
the needs of Australians with diabetes and provide
information that will assist in improving the capability
of the NDSS to meet the needs of its registrants. Dia-
betes MILES–Australia, as described here, also repre-
sents the first step towards establishing a longitudinal
program of research.
Diabetes MILES–Australia has been met with consid-
erable enthusiasm by people with diabetes in Australia.
Many participants commented on the significance of the
study for them personally and for people with diabetes
generally. Both the survey and the cognitive debriefing
Table 2 Response rates for postal versus online survey*
State/territory Total respondents N (%) Respondents to postal survey N (%) Respondents to online survey N (%)
Total sample 3338 (100) 2351 (70.4) 987 (29.6)
Type 1 diabetes 1376 (41.2) 865 (36.8) 511 (51.8)
ACT 39 (1.2) 17 (0.7) 22 (2.3)
NSW 295 (9.0) 233 (10.0) 62 (6.4)
NT 19 (0.6) 19 (0.8) 0 (0.0)
QLD 266 (8.1) 203 (8.7) 63 (6.5)
SA 68 (2.1) 53 (2.3) 15 (1.6)
TAS 30 (0.9) 21 (0.9) 9 (0.9)
VIC 497 (15.1) 200 (8.6) 297 (30.9)
WA 137 (4.2) 113 (4.8) 24 (2.5)
Type 2 diabetes 1962 (58.8) 1486 (63.2) 476 (48.2)
ACT 28 (0.8) 22 (0.9) 6 (0.6)
NSW 477 (14.5) 427 (18.3) 50 (5.2)
NT 66 (2.0) 66 (2.8) 0 (0.0)
QLD 327 (9.9) 284 (12.2) 43 (4.5)
SA 135 (4.1) 130 (5.6) 5 (0.5)
TAS 64 (1.9) 59 (2.5) 5 (0.5)
VIC 646 (19.6) 328 (14.1) 318 (33.1)
WA 199 (6.0) 156 (6.7) 43 (4.5)
Men 1525 (46.2) 1137 (48.9) 387 (39.6)
18-24 years 47 (1.4) 37 (1.6) 10 (1.0)
25-34 years 103 (3.1) 70 (3.0) 33 (3.4)
35-44 years 152 (4.6) 106 (4.6) 46 (4.7)
45-54 years 292 (8.8) 206 (8.9) 86 (8.8)
55-64 years 560 (17.0) 408 (17.6) 152 (15.5)
65-70 years 370 (11.2) 310 (13.3) 60 (6.1)
Women 1778 (53.8) 1187 (51.1) 591 (60.4)
18-24 years 126 (3.8) 94 (4.0) 32 (3.3)
25-34 years 226 (6.8) 128 (5.5) 98 (10.0)
35-44 years 259 (7.8) 150 (6.5) 109 (11.1)
45-54 years 387 (11.7) 237 (10.2) 150 (15.3)
55-64 years 502 (15.2) 355 (15.3) 147 (15.0)
65-70 years 278 (8.4) 223 (9.6) 55 (5.6)
ACT: Australian Capital Territory; NSW: New South Wales; NT: Northern Territory; QLD: Queensland; SA: South Australia; TAS: Tasmania; VIC: Victoria; WA: Western
Australia
* Table refers only to eligible participants. Total N is not always consistent with total sample size due to missing data on some items
Speight et al. BMC Public Health 2012, 12:120
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Table 3 Sample characteristics: Diabetes MILES–Australia 2011 cohort
N (%) or Mean ± SD (Range)
Type 1 Type 2 N (%) Total N* (%)
TOTAL 1376 (41.2) 1962 (58.8) 3338 (100)
Gender–female 825 (60.6) 953 (49.1) 1778 (53.8)
Age–years 41.98 ± 13.96 (18-70) 58.55 ± 8.71 (19-70) 51.71 ± 13.84 (18-70)
Aboriginal or Torres Strait Islander origin 10 (1.0) 39 (2.1) 49 (1.7)
Main language spoken at home–English 1322 (96.1) 1882 (95.9) 3204 (96.0)
Country of birth–Australia 1061 (77.8) 1412 (72.4) 2473 (74.6)
Marital status
Single 257 (18.9) 193 (9.9) 450 (13.6)
Steady relationship 99 (7.3) 26 (1.3) 125 (3.8)
Married or De facto relationship 895 (65.9) 1375 (70.7) 2270 (68.7)
Separated 25 (1.8) 58 (3.0) 83 (2.5)
Divorced 68 (5.0) 187 (9.6) 255 (7.7)
Widowed 13 (1.0) 83 (4.3) 96 (2.9)
Education
No qualifications 57 (4.2) 209 (10.8) 266 (8.1)
School/Intermediate Certificate 83 (6.1) 259 (13.4) 342 (10.4)
High School/Leaving Certificate 261 (19.2) 370 (19.1) 631 (19.1)
Trade/Apprenticeship 95 (7.0) 167 (8.6) 262 (7.9)
Certificate/Diploma 293 (21.5) 428 (22.1) 721 (21.6)
University degree 341 (25.1) 241 (12.4) 582 (17.7)
Higher university degree 190 (14.0) 162 (8.4) 352 (10.5)
Occupation
Unemployed 86 (6.4) 151 (7.8) 237 (7.2)
Full time student 82 (6.1) 13 (0.7) 95 (2.9)
Retired 134 (9.9) 744 (38.5) 878 (26.8)
Homemaker/Carer/Volunteer 106 (7.8) 168 (8.7) 274 (8.4)
Labourer 66 (4.9) 82 (4.2) 148 (4.5)
Clerical/Sales/Service 222 (16.4) 221 (11.5) 443 (13.5)
Tradesperson 78 (5.8) 84 (4.4) 162 (4.9)
Associate professional 158 (11.7) 152 (7.9) 310 (9.4)
Professional 368 (27.2) 240 (12.4) 608 (18.5)
Director 37 (2.7) 38 (2.0) 75 (2.3)
Annual household income ($)
≤ 20,000 162 (12.3) 434 (23.7) 596 (18.9)
20,001-40,000 144 (10.9) 415 (22.7) 559 (17.8)
40,001-60,000 218 (16.6) 363 (19.8) 581 (18.5)
60,001-100,000 358 (27.2) 341 (18.6) 699 (22.2)
100,001-150,000 246 (18.7) 181 (9.9) 427 (13.6)
> 150,000 187 (14.2) 93 (5.1) 280 (8.9)
Geographical location
Metropolitan 793 (58.7) 907 (47.0) 1700 (51.8)
Regional 369 (27.3) 555 (28.8) 924 (28.2)
Rural 186 (13.8) 464 (24.0) 650 (19.8)
*Total N reported in this table not always consistent with total sample size due to missing data on some items
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interview sessions enabled participants to “have a voice”,
expressing their thoughts, opinions, feelings and experi-
ences of living with diabetes and healthcare provision.
The Diabetes MILES Study is now an international
collaborative, with several colleagues making prepara-
tions to undertake similar initiatives in their own coun-
tries. Under the leadership of Prof Frans Pouwer of
Tilburg University, the first to get underway is Diabetes
MILES–The Netherlands, which completed its data col-
lection in October 2011. Both datasets have included a
core set of questions and measures (identified in Table
1) in order to have sufficient commonality of variables
to enable meaningful international comparisons and
pooling of data. Those interested in joining the Diabetes
MILES Study International Collaborative are invited to
contact Prof Jane Speight or Prof Frans Pouwer.
Limitations
Surveying NDSS registrants who have consented to be
contacted about research may not provide a fully repre-
sentative sample of people with diabetes [54]. It is esti-
mated that up to 50% of Australians with type 2
diabetes are undiagnosed, do not know they have the
condition, and therefore are not on the register [55].
Registration information may include inaccurate or out-
dated details, such as diagnosis (e.g. type 1 when actu-
ally type 2 insulin-treated), treatment or demographics.
The NDSS database is routinely cleansed, at least every
six months, to correct or remove inaccurate age listings,
addresses and update registrant deaths. However, in
spite of this, 541 survey packages were returned to sen-
der, because the addressee was either no longer residing
at the address or was deceased.
Among the random sample of 15,000 registrants,
1,556 (10%) were listed as having carers. Two-thirds of
carers (n = 1,023) were for registrants listed as having
type 1 diabetes. In the instance where a carer was listed,
the survey was automatically addressed to the carer, as
is the default system on the NDSS database. In some
instances, the carer listing was some years out of date.
As such, some surveys may have been ignored, possibly
lowering the response rate, simply due to the listed
carer no longer being responsible for, living with, or in
contact with the registrant.
Men account for 53% of NDSS adult registrants, and
our sample included only 46% men. However, given that
men are often more reluctant to participate in research
(especially of a psychosocial nature), we were satisfied
with this response. Further, although more than half of
our sample were from just two of the eight Australian
states and territories (namely New South Wales and
Victoria), this reflects the proportion of NDSS regis-
trants who reside in these states.
People of ATSI descent were under-represented in our
sample, as were people of lower socioeconomic back-
grounds, and people whose main language was not Eng-
lish. Diabetes MILES–Australia as it is described here
was not designed specifically to meet the needs of peo-
ple from culturally and linguistically diverse back-
grounds, nor was it available in other languages, and so
this result is unsurprising. Future Diabetes MILES–Aus-
tralia initiatives may be tailored to meet the needs of
these sub-populations to improve the accessibility of the
study for these groups. However, reflective of the
broader Australian population, a quarter of our sample
indicated that they were born abroad.
The online survey was more likely to be completed
by people with type 1 diabetes, women, younger adults,
and those from Victoria or New South Wales. With
the research team based in Victoria, there were more
opportunities to advertise in Victorian media than in
other states. Also, there were more opportunities to
advertise in media aimed at adults with type 1 dia-
betes. Although older adults had lower rates of partici-
pation in the online survey than their younger
counterparts, more than 20% of the online survey sam-
ple was aged over 55 years, and those who took part
spanned the whole eligible age range (18-70 years),
suggesting that online research is not inaccessible to
older adults.
Conclusions
Diabetes MILES–Australia represents a major
achievement in the study of diabetes in Australia,
where there has been limited published research on
the psychosocial and behavioural aspects of this con-
dition. For the first time, an in-depth study has been
conducted at a national level, which has the potential
to provide much needed data on a range of important
psychological outcomes hitherto neglected. Diabetes
MILES–Australia also represents the baseline of a
longitudinal cohort study, which will enable prospec-
tive investigation of psychological outcomes and how
they relate to the natural history of diabetes, its treat-
ment and the onset of complications and other co-
morbidities.
Endnotes
a State-based data accurate as of 30 June 2011. b Gen-
der-based data accurate at December 2010.
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